Skip to main content
AngioLab, Inc. logo

AngioLab, Inc. — Investor Relations & Filings

Ticker · 251280 ISIN · KR7251280004 KO Professional, scientific and technical activities
Open in API
Filings indexed 173 across all filing types
Latest filing 2021-10-27 Report Publication Anno…
Country KR South Korea
Listing KO 251280

About AngioLab, Inc.

https://angiolab.co.kr/

AngioLab, Inc. is a biotechnology company specializing in the discovery and development of angiogenesis inhibitors. The company develops pharmaceuticals and health functional foods to treat diseases associated with the abnormal growth of blood vessels. Its pipeline includes drug candidates targeting conditions such as age-related macular degeneration (AMD), with some candidates having undergone Phase II clinical trials. AngioLab has also developed Ob-X, a functional food ingredient based on its anti-angiogenic research platform.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement (928 characters) regarding the scheduling and details of an upcoming Investor Relations (IR) meeting. It provides the date, time, location, and purpose of the event, but it is not the presentation material itself. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Report Publication Announcement (RPA) or a general regulatory filing. Given the specific nature of announcing an IR event, RPA is the most appropriate classification.
2021-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a South Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure required by the Financial Supervisory Service (FSS) when a major shareholder or executive changes their stake in a company. Since the document details the specific share transactions (disposals) by a major shareholder (Delta Investment, LLC) in the company (Angiolab), it falls under the category of 'Director's Dealing' (DIRS), which covers insider/major shareholder trading reports.
2021-09-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required under the Capital Markets Act when an entity or individual acquires a significant stake (typically 5% or more) in a company. It details the reporting entity, special relationships, and changes in share ownership. This corresponds to the 'Major Shareholding Notification' category in the provided schema.
2021-08-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details changes in share ownership by a major shareholder (Delta Investment, LLC) in a listed company (AngioLab). This type of filing is specifically for reporting insider or major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema, as it tracks personal/entity share transactions by major stakeholders.
2021-08-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details the change in share ownership (specifically a decrease due to market sales) by 'Delta 1st Startup and Venture Private Equity Fund' in the company 'Angiolab'. This type of filing is a standard regulatory requirement for major shareholders to disclose changes in their holdings, which falls under the 'Major Shareholding Notification' category.
2021-08-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to report changes in shareholdings by insiders or major shareholders, which corresponds to the 'Director's Dealing' category in the provided taxonomy.
2021-08-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.